Method of treating brain tumors expressing tenascin
AssigneeDuke University
InventorsDarell D. Bigner, Michael R. Zalutsky
Life of this patent
Estimating the term…
Loading patent…
AssigneeDuke University
InventorsDarell D. Bigner, Michael R. Zalutsky
Estimating the term…
Methods of treating solid and cystic tumors are disclosed. The method comprises administering to a subject afflicted with a cystic tumor an antibody which binds to tenascin in a therapeutically effective amount. The administering step is carried out by depositing the antibody in the cyst cavity of the cystic tumor. For solid tumors, disclosed is a method involving first, removing a solid tumor from a solid tissue organ of an afflicted subject; then forming an enclosed resection cavity in the organ of the subject at the location from which the solid tumor was removed; and then administering to the subject an antineoplastic agent by depositing the antineoplastic agent in the resection cavity. Particularly preferred for carrying out the foregoing is the monoclonal antibody 81C6 and antibodies which bind to the epitope bound by monoclonal antibody 81C6.
A method of treating a cystic brain tumor which expresses tenascin, comprising:
A method of treating a cystic astrocytic brain tumor which expresses tenascin, comprising:
A method of treating a solid brain tumor which expresses tenascin, in a human subject in need of such treatment, comprising:
A method of treating a solid astrocytic tumor which expresses tenascin in the brain of a human subject in need of such treatment, comprising:
Dependencies are inferred from the claim text.